Children's Dementia: A Race Against Time

Families are urgently seeking government support for children with rare conditions like Sanfilippo syndrome, often referred to as childhood dementia. These families are racing against time, with many exploring clinical trials or fundraising millions for life-saving treatments abroad. The cost of gene therapy for type A Sanfilippo, Fayuvi, is approximately $3.95 million, presenting a significant financial hurdle for parents.

Childhood dementia can progressively diminish a child's abilities, with some children not expected to live past their teenage years. Researchers estimate hundreds of children die annually from conditions causing childhood dementia in the UK. Parents often report shock at the limited support following diagnosis, describing a lack of clear guidance and immediate care pathways.

The push for government action intensifies ahead of World Sanfilippo Awareness Day, with parents advocating for childhood dementia to be recognized in national policy and research funding. Despite a recent £48 million investment in dementia research, childhood dementia was not mentioned, leading to frustration and calls for equal prioritization. The UK is reviewing the US-approved therapy for licensing, but parents fear delays could prove fatal for their children.

Many families are fundraising extensively, with some exceeding £500,000, while still facing immense pressure and emotional strain. They also report needing to educate healthcare professionals about the rare conditions their children face. Health officials state that the NHS is improving diagnosis and specialist care for rare diseases, including Sanfilippo syndrome.